Prokidney Corp.
prokidney.comProKidney offers treatment of chronic kidney disease (CKD) through innovations in cellular therapy. ProKidney’s lead product candidate, REACT™ (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT™ has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting its ongoing Phase 3 clinical program.
Is this your company?
If you're responsible for hiring at this company, make sure your company and job information are always up to date to attract top talent from the North Carolina Biotechnology Center network.
Something looks off?
Open jobs at Prokidney Corp.
On-site & Remote
Job function
Seniority
Salary